HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishiwata, K. Articles by Woldring, M. G. Search for Related Content PubMed PubMed Citation Articles by Ishiwata, K. Articles by Woldring, M. G.

Comparison of L-[1-¹¹C]Methionine and L-Methyl-[¹¹C]Methionine for Measuring In Vivo Protein Synthesis Rates with PET

Department of Nuclear Medicine, University Hospital, Groningen, The Netherlands

Correspondence: For reprints contact: W. Vaalburg, MD, Dept. of Nuclear Medicine, University Hospital, Oostersingel 59, 9713 EZ Groningen, The Netherlands

ABSTRACT

To evaluate the feasibility of using either L-[1-¹¹C]-methionine or L-[methyl-¹¹C]methionine for measuring protein synthesis rates by positron emission tomography (PET) in normal and neoplastic tissues, distribution and metabolic studies with ¹⁴C-and ¹¹C-labeled methionines were earned out in rats bearing Walker 256 carcinosarcoma. The tissue distributions of the two ¹⁴C-labeled methionines were similar except for liver tissue. Similar distribution patterns were observed in vivo by PET using ¹¹C-labeled methionines. The highest ¹⁴C incorporation rate into the protein-bound fraction was found in the liver followed by tumor, brain, and pancreas. The incorporation rates in liver and pancreas were different for the two methionines. By chloroform-methanol fractionation of these four tissues, in liver significantly different amounts of ¹⁴C were observed in macromolecules. Also in brain tissue slight differences were found. By HPLC analyses of the protein-free fractions of plasma, tumor, and brain tissue at 60 min after injection, for both methionines several ¹⁴C-labeled metabolites in different amounts, were detected. About half of the ¹⁴C-labeled material in the protein-free fraction was found to be methionine. In these three tissues the amount of nonprotein metabolites and [¹⁴C]bicarbonate amount ranged from 10% to 17% and 12% to 15% for L-[1-¹⁴C] methionine and L-[methyl-¹⁴C]methionine, respectively. From these results it can be concluded that the minor metabolic pathways have to be investigated in order to quantitatively model the protein synthesis by PET.

FOOTNOTES

Dr. K. Ishiwata is on leave of absence from the Division of Radioisotope Research, Cyclotron and Radioisotope Center, Tohoku University, Sendai, 980, Japan

This article has been cited by other articles:

				H. Tsukada, K. Sato, D. Fukumoto, S. Nishiyama, N. Harada, and T. Kakiuchi Evaluation of D-Isomers of O-11C-Methyl Tyrosine and O-18F-Fluoromethyl Tyrosine as Tumor-Imaging Agents in Tumor-Bearing Mice: Comparison with L- and D-11C-Methionine J. Nucl. Med., April 1, 2006; 47(4): 679 - 688. [Abstract] [Full Text] [PDF]

				R. Hustinx, C. Lemaire, G. Jerusalem, P. Moreau, D. Cataldo, B. Duysinx, J. Aerts, M.-F. Fassotte, J. Foidart, and A. Luxen Whole-Body Tumor Imaging Using PET and 2-18F-Fluoro-L-Tyrosine: Preliminary Evaluation and Comparison with 18F-FDG J. Nucl. Med., April 1, 2003; 44(4): 533 - 539. [Abstract] [Full Text] [PDF]